Smooth muscle cell phenotypic switching occurs independent of aortic dilation in bicuspid aortic valve-associated ascending aortas
- PMID: 38954721
- PMCID: PMC11218944
- DOI: 10.1371/journal.pone.0306515
Smooth muscle cell phenotypic switching occurs independent of aortic dilation in bicuspid aortic valve-associated ascending aortas
Abstract
Background: Bicuspid aortic valves (BAV) are frequently associated with ascending aortic aneurysms. The etiology is incompletely understood, but genetic factors, in addition to flow perturbations, are likely involved. Since loss of contractility and elaboration of extracellular matrix in the vessel wall are features of BAV-associated aortopathy, phenotypic modulation of smooth muscle cells (SMCs) may play a role.
Methods: Ascending aortic tissue was collected intra-operatively from 25 individuals with normal (i.e., tricuspid) aortic valves (TAV) and from 25 individuals with BAVs. For both TAV and BAV, 10 patients had non-dilated (ND) and 15 patients had dilated (D) aortas. SMCs were isolated and cultured from a subset of patients from each group. Aortic tissue and SMCs were fluorescently immunolabeled for SMC phenotypic markers (i.e., alpha-smooth muscle actin (ASMA, contractile), vimentin (synthetic) and p16INK4a and p21Cip1 (senescence). SMCs were also analyzed for replicative senescence in culture.
Results: In normal-sized and dilated BAV aortas, SMCs switched from the contractile state to either synthetic or senescent phenotypes, as observed by loss of ASMA (ND: P = 0.001, D: P = 0.002) and associated increases in vimentin (ND: P = 0.03, D: P = 0.004) or p16/p21 (ND: P = 0.03, D: P<0.0001) compared to TAV. Dilatation of the aorta exacerbated SMC phenotypic switching in both BAV and TAV aortas (all P<0.05). In SMCs cultured from normal and dilated aortas, those isolated from BAV reached replicative senescence faster than those from TAV aortas (all P = 0.02). Furthermore, there was a stark inverse correlation between ASMA and cell passage number in BAV SMCs (ND: P = 0.0006, D: P = 0.01), but not in TAV SMCs (ND: P = 0.93, D: P = 0.20).
Conclusions: The findings of this study provide direct evidence from cell culture studies implying that SMCs switch from the contractile state to either synthetic or senescent phenotypes in the non-dilated BAV aorta. In cultured SMCs from both non-dilated and dilated aortas, we found that this process may precede dilatation and accompany aneurysm development in BAV. Our findings suggest that therapeutically targeting SMC phenotypic modulation in BAV patients may be a viable option to prevent or delay ascending aortic aneurysm formation.
Copyright: © 2024 Balint et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
Similar articles
-
Seno-destructive smooth muscle cells in the ascending aorta of patients with bicuspid aortic valve disease.EBioMedicine. 2019 May;43:54-66. doi: 10.1016/j.ebiom.2019.04.060. Epub 2019 May 9. EBioMedicine. 2019. PMID: 31078518 Free PMC article.
-
Aortic regurgitation provokes phenotypic modulation of smooth muscle cells in the normal ascending aorta.J Thorac Cardiovasc Surg. 2023 Dec;166(6):1604-1616.e1. doi: 10.1016/j.jtcvs.2023.07.025. Epub 2023 Jul 25. J Thorac Cardiovasc Surg. 2023. PMID: 37500054
-
Targeted gene expression analyses and immunohistology suggest a pro-proliferative state in tricuspid aortic valve-, and senescence and viral infections in bicuspid aortic valve-associated thoracic aortic aneurysms.Atherosclerosis. 2018 Apr;271:111-119. doi: 10.1016/j.atherosclerosis.2018.02.007. Epub 2018 Feb 5. Atherosclerosis. 2018. PMID: 29486395
-
Defective NOTCH signaling drives increased vascular smooth muscle cell apoptosis and contractile differentiation in bicuspid aortic valve aortopathy: A review of the evidence and future directions.Trends Cardiovasc Med. 2019 Feb;29(2):61-68. doi: 10.1016/j.tcm.2018.06.008. Epub 2018 Jun 21. Trends Cardiovasc Med. 2019. PMID: 30621852 Review.
-
Bicuspid Aortic Valves: an Up-to-Date Review on Genetics, Natural History, and Management.Curr Cardiol Rep. 2022 Aug;24(8):1021-1030. doi: 10.1007/s11886-022-01716-2. Epub 2022 Jul 22. Curr Cardiol Rep. 2022. PMID: 35867195 Review.
References
-
- Michelena HI, Prakash SK, Della Corte A, Bissell MM, Anavekar N, Mathieu P, et al.. Bicuspid aortic valve: identifying knowledge gaps and rising to the challenge from the International Bicuspid Aortic Valve Consortium (BAVCon). Circulation. 2014;129:2691–2704. doi: 10.1161/CIRCULATIONAHA.113.007851 - DOI - PMC - PubMed
-
- Mahadevia R, Barker AJ, Schnell S, Entezari P, Kansal P, Fedak PW, et al.. Bicuspid aortic cusp fusion morphology alters aortic three-dimensional outflow patterns, wall shear stress, and expression of aortopathy. Circulation. 2014;129:673–682. doi: 10.1161/CIRCULATIONAHA.113.003026 - DOI - PMC - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical